Molecular markers of hemostasis and fibrinolysis and inhibitor levels in unstable angina pectoris

Fibrinolysis and Proteolysis

Volumn 11, Issue SUPPL. 1, 1997, Pages 61-65

  Hoffmeister, H M ^a,b   Heller, W ^a   Seipel, L ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CONFERENCE PAPER; CORONARY ARTERY BLOOD FLOW; DIAGNOSTIC VALUE; FIBRINOLYSIS; HEMOSTASIS; HUMAN; PATHOGENESIS; PRIORITY JOURNAL; THROMBOGENESIS; UNSTABLE ANGINA PECTORIS;

EID: 0030701860     PISSN: 13690191     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0268-9499(97)80025-2     Document Type: Conference Paper

References (42)

1. Davis MJ, Thomas A. Thrombosis and acute coronary artery lesions in sudden cardiac ischemic death. N Engl J Med 1984; 310: 1137-1140.
2. Freeman M R, William A E, Chisholm RJ, Armstrong P W. Intracoronary thrombus and complex morphology in unstable angina. Circulation 1989; 80: 17-23.
3. Neri Serneri G G, Gensini G F, Abbate R, Laureano R, Parodi O. Is raised plasma fibrinopeptide A a marker of acute coronary insufficiency? Lancet 1980; 2: 982-983.
4. Ambrose J A, Winters S L, Stern A, Eng A, Teicholz L E, Gorlin R, Fuster V. Angiographic morphology and the pathogenesis of unstable angina pectoris. J Am Coll Cardiol 1985; 5: 609-616.
5. Ardissino D, Merlini P A, Gamba G et al. Thrombin activity and early outcome in unstable angina pectoris. Circulation 1996; 93: 1634-1639.
6. Alexopoulos D, Ambrose J A, Stump D, Borrico S, Gorlin R, Deshmukh P, Fisher E A. Thrombosis-related markers in unstable angina pectoris. J Am Coll Cardiol 1991; 17: 866-871.
7. Théroux P, Latour J G, Léger-Gauthier C, De Lara J. Fibrinopeptide A and platelet factor levels in unstable angina pectoris. Circulation 1987; 75: 156-162.
8. Eisenberg P R, Kenzora J L, Sobel B E, Ludbrook P A, Jaffe A S. Relation between S T segment shifts during ischemia and thrombin activity in patients with unstable angina pectoris. J Am Coll Cardiol 1991; 18: 898-903.
9. Hoffmeister H M, Beyer M E, Engel Z, Heller W. Fibrinogen, prekallikrein and kallikrein-like-activity in patients with unstable angina pectoris. In: E Ernst, W Koenig, G D O Lowe, T W Meade (eds.) Fibrinogen: a 'new' cardiovascular risk factor. Blackwell-MZV, Wien, 1992: 188-191.
10. Rennie J A, Ogston D. Changes in coagulation factors following acute myocardial infarction in man. Haemostasis 1976; 5: 258-264.
11. Munkvad S, Jespersen J, Gram J, Kluft C. Long-lasting depression of the factor XII-dependent fibrinolytic system in patients with myocardial infarction undergoing thrombolytic therapy with recombinant tissue-type plasminogen activator: a randomized placebo-controlled study. J Am Coll Cardiol 1991; 17: 957-962.
12. Munkvad S, Gram J, Jespersen J. A depression of active tissue plasminogen activator in plasma characterizes patients with unstable angina pectoris who develop myocardial infarction. Eur Heart J 1990; 11: 525-528.
13. Zalewski A, Shi Y, Nardone D, Bravette B, Weinstock P, Fischmann D, Wilson P, Goldberg S, Levin D C, Bjornsson T D. Evidence for reduced fibrinolytic activity in unstable angina at rest. Circulation 1991; 83: 1685-1691.
14. Kruskal JB, Commerford PJ, Franks JJ, Kirsch RE. Fibrin and fibrinogen-related antigens in patients with stable and unstable coronary artery disease. N Engl J Med 1987; 317: 1361-1365.
15. Hoffmeister H M, Jur M, Wendel H P, Heller W, Seipel L. Alterations of coagulation and fibrinolytic and kallikrein-kinin system in the acute and postacute phases in patients with unstable angina pectoris. Circulation 1995; 91: 2520-2527.
16. Carvalho de Sousa J, Azevedo J, Soria C, Barros F, Ribeiro C, Parreira F, Caen J P. Factor VII hyperactivity in acute myocardial thrombosis. A relation to the coagulation activation. Thromb Res 1988; 51: 165-173.
17. Oshima S, Uchida K, Yasu T, Uno K, Nonogi H, Haze K. Transient increase of plasma lipoprotein (a) in patients with unstable angina pectoris. Does lipoprotein (a) alter fibrinolysis? Arterioscler Thromb 1991; 11: 1772-1777.
18. Merlini P A, Bauer K A, Oltrona L, Ardissino D, Cattaneo M, Belli C, Mannucci P M, Rosenberg R D. Persistent activation of coagulation mechanism in unstable angina and myocardial infarction. Circulation 1994; 90: 61-68.
19. Hoffmeister H M, Helber U, Jur M, Wendel H P, Heuer W, Seipel L. Disturbed fibrinolysis in unstable angina pectoris: morphological and prognostic aspects. Eur Heart 1996; 17 (Suppl.): 299.
20. Gallimore MJ. Plasma-Präkallikrein. Hämostaseologie 1987; 7: 166-171.
21. Golikov A P, Bobkov A I, Ivleva VI. Changes in sympathoadrenal and kallikrein-kinin systems in the terminal stage of extensive myocardial infarction. Cor Vasa 1977; 19: 169-175.
22. Torstilla I. The plasma kinin system in acute myocardial infarction. Acta Med Scand 1978; Suppl 620: 1-62
23. Lucore C L, Sobel B E. Interactions of tissue-type plasminogen activator with plasma inhibitors and their pharmacologic implications. Circulation 1988; 77: 660-669.
24. Berk B C, Weintraub W S, Alexander R W. Elevation of C-reactive protein in 'active' coronary artery disease. Am J Cardiol 1990; 65: 168-172.
25. Munkvad S, Jespersen J, Gram J, Kluft C. Interrelationship between coagulant activity and tissue-type plasminogen activator (t-PA) system in acute ischaemic heart disease. Internal Med 1990; 228: 361-366.
26. Hamsten A, Walldius G, Szamosi A, Blombäck M, De Faire U, Dahlen G, Landou C, Wiman B. Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet 1987; 3-9.
27. Wiman B, Hamsten A. Correlations between fibrinolytic function and acute myocardial infarction. Am J Cardiol 1990; 66: 54G-56G.
28. Hamsten A, Wiman B, De Faire U, Blombaeck M. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N Engl J Med 1985; 313: 1557-1563.
29. Francis R B, Kawanishi D, Baruch T, Mahrer P, Rahimtoola S, Feinstem DI. Impaired fibrinolysis in coronary artery disease. Am Heart J 1988; 115: 776-780.
30. Hoffmeister H M, Jur M, Ruf M, Wendel H P, Heller W. Decreased fibrinolytic reserve capacity of the endothelium in patients with acute coronary syndrome. Circulation 1995; 92: 1-341.
31. ECAT angina pectoris study group. ECAT angina pectoris study: baseline associations of haemostatic factor with extent of coronary arteriosclerosis and other coronary risk factors in 3000 patients with angina pectoris undergoing coronary angiography. Europ Heart J 1993; 14: 8-17.
32. Marder V J. What does the 'dimer test' test? Circulation 1990; 82: 1514-1515.
33. Folsom A R, Wu K K, Shahar E, Davis C E. For the atherosclerosis risk in communities (ARIC) study investigators. Association of hemostatic variables with prevalent cardiovascular disease and asymptomatic carotid artery atherosclerosis. Arterioscler Thromb 1993; 13: 1829-1836.
34. Meade T W, Ruddock V, Stirling Y, Chakrabarti R, Miller G J. Fibrinolytic activity, clotting factors, and long-term incidence of ischemic heart disease in the Northwick Park Heart Study. Lancet 1993; 342: 1076-1079.
35. Geppert A, Beckman R, Graf S, et al. Tissue-type plasminogen activator and type-1 plasminogen activator inhibitor in patients with coronary artery disease - relations to clinical variables and cardiovascular risk factors. Fibrinolysis 1995; 9 (suppl 1): 109-113.
36. Dawson S, Henney A. The status of PAI-1 as a risk factor for arterial and thrombotic disease. Atherosclerosis 1992; 95: 105-117.
37. Jansson J H, Olofsson B O, Nilsson T K. Predictive value of tissue plasminogen activator mass concentration on long term mortality in patients with coronary artery disease. A 7 year follow-up. Circulation 1993; 88: 2030-2034.
38. Weczoredk I, Ludlam C A, Fox K K A. Tissue-type plasminogen activator and plasminogen activator inhibitor activities as predictors of adverse events in unstable angina. Am J Cardiol 1994; 74: 424-429.
39. Huber K, Hornykewycz S, Angles-Cano E. Risikoprädiktion und Sekundärprävention bei Angina pectoris und nach Herzinfarkt. Der Internist 1995; 36: 883-890.
40. Vaziri N D, Kennedy S C, Kennedy D, Gonzales E. Coagulation, fibrinolytic, and inhibitory proteins in acute myocardial infarction and angina pectoris. Am J Med 1992; 93: 651-657.
41. Jur M, Heller W, Hoffmeister H M. Verhalten plasmatischer Inhibitoren bei Patienten mit akutem Myokardinfarkt in Relation zum Fibrinogen. In: H Heinle, H Schulte, H Kaffarnik (eds.) Arteriosklerose. W. Kohlhammer, Stuttgart, 1995: 355-358.
42. Hoffmeister H M, Jur M, Ruf M, Heller W, Seipel L. Inhibitors of the hemostasis and related systems in patients with acute myocardial infarction or unstable angina pectoris. Fibrinolysis 1995; 9: 104-108.